Table 1.2 Trachoma screening coverage, trachoma prevalence and clean face prevalence in children aged 5-9 years by jurisdiction, Australia 2016 Northern Territory South Australia Western Australia Queensland Total Number of communities screened 47 19 37 3 106 Age group (years) 5-9 5-9 5-9 5-9 5-9 Children examined for clean face 1689 637 890 153 3369 Children with clean face 1179 480 659 141 2459 Clean face prevalence (%) 70 75 74 92 73 Estimated number* of Indigenous children in communities† 1774 706 781 165 3426 Children screened for trachoma 1628 637 725 153 3143 Trachoma screening coverage (%) 92 90 93 93 92 Children with active trachoma 130 29 16 0 175 Observed prevalence of active trachoma (%) 8.0 4.6 2.2 0 5.6 Estimated prevalence of active trachoma (%) 6.5 4.5 5.7 0 6.6 Overall prevalence of active trachoma (%) 6.1 2.8 3.5 0 4.7 * Jurisdictional estimate † Communities that were screened for trachoma in 2016 ‡ Methods of calculating prevalence rates on page 16 § 14 children in QLD were identified with follicles meeting WHO simplified grading scheme for TF. Ophthalmologist review identified no corneal pannus or Herbert’s pits. These children were assessed as not having active trachoma
Table 2.1 Trachoma control delivery in at-risk* communities by region, Northern Territory 2016 Number of communities Alice Springs Remote Barkly Darwin Rural East Arnhem Katherine Total At risk * (A) 27 11 11 9 19 77 Requiring screening for trachoma (B) 18 6 6 5 17 52 Screened for trachoma (C) 18 2 6 4 17 47 Requiring treatment without screening † (D) 7 4 0 0 1 12 Received treatment without screening † (E) 7 0 0 0 1 8 Screened and/or treated for trachoma (F = C+E) 25 2 6 4 18 55 Requiring neither screening or treatment for trachoma 2 1 5 4 1 13 * As defined by each jurisdiction † As per Guidelines
Overall prevalence of active trachoma‡ (%) N/A 13.9 N/A N/A N/A 9.4 N/A N/A N/A 1.2 N/A N/A N/A 1.1 N/A N/A N/A 7.1 N/A N/A N/A 6.1 N/A N/A * Jurisdiction provides estimate for children aged 5-9 years only; number of children in communities aged 0-4 and 10-14 years are based on convenience sampling † In communities that were screened for trachoma in 2016 ‡ Methods of calculating the different prevalence figures on page 16 Table 2.3 Number and proportion of at-risk communities according to level of trachoma prevalence* in children aged 5-9 years, Northern Territory 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Communities at-risk † 89 87 86 86 86 82 80 78 78 77 Communities not screened ‡ 25 25 33 21 19 4 12 0 8 8 Number of communities § 60 43 53 64 65 76 68 78 70 69 ≥20% 12 20% 25 58% 19 36% 27 42% 9 14% 5 7% 5 7% 14 18% 11 16% 11 16% ≥10% but <20% 8 13% 6 14% 8 15% 4 6% 9 14% 9 12% 14 21% 14 18% 11 16% 13 19% ≥5% but <10% 4 7% 4 9% 3 6% 9 14% 11 17% 9 12% 9 13% 10 13% 7 10% 8 12% >0% but <5% 7 12% 4 9% 9 17% 9 14% 14 22% 13 17% 9 13% 6 8% 10 14% 9 13% 0% 29 48% 4 9% 14 26% 15 23% 22 34% 40 53% 31 46% 34 44% 31 44% 28 41% * Based on current or most recent year † As defined annually by each jurisdiction ‡ Or treated as required per Guidelines § Screened or receiving ongoing annual treatment as per Guidelines
Table 3.2 Trachoma screening coverage, trachoma prevalence and clean face prevalence by region, South Australia 2016 APY Lands Eyre and Western Far North Total Number of communities screened 9 4 6 19 Age group (years) 0-4 5-9 10-14 0-14 0-4 5-9 10-14 0-14 0-4 5-9 10-14 0-14 0-4 5-9 10-14 0-14 Children examined for clean face 213 249 233 695 21 128 110 259 154 260 185 599 388 637 528 1553 Children with clean face 118 130 226 474 15 118 107 240 131 232 174 537 264 480 507 1251 Clean face prevalence (%) 55 52 97 68 71 92 97 93 85 89 94 90 68 75 96 81 Estimated number* of Aboriginal children in communities† 249 273 244 766 175 144 137 456 312 289 295 896 736 706 676 2118 Children screened for trachoma 213 249 233 695 21 128 110 259 154 260 185 599 388 637 528 1553 Trachoma screening coverage (%) 86 91 95 91 12 89 80 57 49 90 63 67 53 90 78 73 Children with active trachoma 3 11 2 16 0 3 1 4 0 15 5 20 3 29 8 40 Observed prevalence of active trachoma ‡ (%) 1.4 4.4 0.9 2.3 0.0 2.3 0.9 1.5 0.0 5.8 2.7 3.3 0.8 4.6 1.5 2.6 Estimated prevalence of active trachoma ‡ (%) N/A 4.4 N/A N/A N/A 2.3 N/A N/A N/A 5.8 N/A N/A N/A 4.6 N/A N/A Overall prevalence of active trachoma‡ (%) N/A 4.4 N/A N/A N/A 1.1 N/A N/A N/A 4.5 N/A N/A N/A 2.8 N/A N/A * ABS estimate † Communities that were screened for trachoma in 2016 ‡ Methods of calculating the different prevalence rates on page 16 APY: Anangu Pitjantjatjara Yankunytjatjara
Table 3.4 Treatment strategies by region, South Australia 2016 APY Lands Eyre and Western Far North Total Required treatment for trachoma * 9 3 3 15 Treated for trachoma * 9 3 3 15 Screened and treated 9 3 3 15 Received treatment without screening 0 0 0 0 Received treatment 0 0 1 1 Did not require treatment 0 1 3 4 Treated active trachoma and households 9 3 2 14 Community-wide treatment 0 0 1 1 Not treated according to CDNA guidelines 0 0 0 0 * In 2016 APY Lands aggregated 9 communities into one community for presentation of data; details of the specific number of communities requiring treatment or treated were not supplied APY: Anangu Pitjantjatjara Yankunytjatjara
Table 4.1 Trachoma control delivery by region, Western Australia 2016 Number of communities Goldfields* Kimberley Midwest Pilbara† Total At risk * (A) 19 17 7 8 51 Requiring screening for trachoma (B) 9 16 4 8 37 Screened for trachoma (C) 9 16 4 8 37 Requiring treatment without screening (D) 10 1 2 0 13 Received treatment without screening‡ (E) 10 1 2 0 13 Screened and/or treated for trachoma (F = C+E) 19 17 6 8 50 Requiring neither screening or treatment for trachoma (G=A-B-D) 0 0 1 0 1 * WA aggregated 10 communities in the Goldfields region into one community †WA aggregated four communities in the Pilbara region into one community ‡Communities treated without screening in 2016 as per Guidelines